The Patent Finder

Nucorion Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Nucorion Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Showing 1 to 4 of 4 · Back to Nucorion Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,059,733Gemcitabine Analogs
Formerly held
Lapsed on the fee record
Ended Aug 28, 2022 · High confidence
Lapsed on the fee recordEnded Aug 28, 2022High confidence
US 10,000,521Substituted Gemcitabine Bicyclic Amide Analogs and Treatment Methods Using Same
Formerly held
Lapsed on the fee record
Ended Jun 19, 2022 · High confidence
Lapsed on the fee recordEnded Jun 19, 2022High confidence
US 9,744,186Substituted Gemcitabine Aryl Amide Analogs
Formerly held
Lapsed on the fee record
Ended Aug 29, 2021 · High confidence
Lapsed on the fee recordEnded Aug 29, 2021High confidence
US 9,447,137Substituted Gemcitabine Aryl Amide Analogs
Formerly held
Lapsed on the fee record
Ended Sep 20, 2020 · High confidence
Lapsed on the fee recordEnded Sep 20, 2020High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited